Mogi M - Search Results

1

Inactivation of tyrosine hydroxylase in rat striatum by 1-methyl-4-phenylpyridinium ion (MPP+).

Ozaki N, Nakahara D, Mogi M, Harada M, Kiuchi K, Kaneda N, Miura Y, Kasahara Y, Nagatsu T. Ozaki N, et al. Among authors: mogi m. Neurosci Lett. 1988 Feb 29;85(2):228-32. doi: 10.1016/0304-3940(88)90356-4. Neurosci Lett. 1988. PMID: 2897647

2

Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1beta and nerve growth factor in the striatum.

Mogi M, Togari A, Ogawa M, Ikeguchi K, Shizuma N, Fan D, Nakano I, Nagatsu T. Mogi M, et al. Neurosci Lett. 1998 Jun 26;250(1):25-8. doi: 10.1016/s0304-3940(98)00427-3. Neurosci Lett. 1998. PMID: 9696057

3

Increase in level of tumor necrosis factor (TNF)-alpha in 6-hydroxydopamine-lesioned striatum in rats without influence of systemic L-DOPA on the TNF-alpha induction.

Mogi M, Togari A, Tanaka K, Ogawa N, Ichinose H, Nagatsu T. Mogi M, et al. Neurosci Lett. 1999 Jun 18;268(2):101-4. doi: 10.1016/s0304-3940(99)00388-2. Neurosci Lett. 1999. PMID: 10400088

4

Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content.

Mogi M, Harada M, Kojima K, Kiuchi K, Nagatsu I, Nagatsu T. Mogi M, et al. Neurosci Lett. 1987 Sep 23;80(2):213-8. doi: 10.1016/0304-3940(87)90656-2. Neurosci Lett. 1987. PMID: 2891089

5

Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, L-3,4-dihydroxyphenylalanine decarboxylase, dopamine beta-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus.

Mogi M, Harada M, Kojima K, Kiuchi K, Nagatsu T. Mogi M, et al. J Neurochem. 1988 Apr;50(4):1053-6. doi: 10.1111/j.1471-4159.1988.tb10572.x. J Neurochem. 1988. PMID: 2894407

6

Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson's disease.

Mogi M, Harada M, Kondo T, Riederer P, Nagatsu T. Mogi M, et al. J Neural Transm Park Dis Dement Sect. 1995;9(1):87-92. doi: 10.1007/BF02252965. J Neural Transm Park Dis Dement Sect. 1995. PMID: 7605592

7

Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients.

Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T. Mogi M, et al. Neurosci Lett. 1994 Oct 24;180(2):147-50. doi: 10.1016/0304-3940(94)90508-8. Neurosci Lett. 1994. PMID: 7700568

8

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.

Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T. Mogi M, et al. Neurosci Lett. 1994 Jan 3;165(1-2):208-10. doi: 10.1016/0304-3940(94)90746-3. Neurosci Lett. 1994. PMID: 8015728

9

Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease.

Mogi M, Harada M, Narabayashi H, Inagaki H, Minami M, Nagatsu T. Mogi M, et al. Neurosci Lett. 1996 Jun 14;211(1):13-6. doi: 10.1016/0304-3940(96)12706-3. Neurosci Lett. 1996. PMID: 8809836 Clinical Trial.

10

bcl-2 protein is increased in the brain from parkinsonian patients.

Mogi M, Harada M, Kondo T, Mizuno Y, Narabayashi H, Riederer P, Nagatsu T. Mogi M, et al. Neurosci Lett. 1996 Sep 6;215(2):137-9. Neurosci Lett. 1996. PMID: 8888015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

563 results

Search Page

Filters